Preventing extrinsic mechanisms of bioprosthetic degeneration using polyphenols.

Bioprosthetic heart valve degeneration Extrinsic degenerative mechanisms Intrinsic degenerative mechanisms Polyphenols

Journal

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
ISSN: 1873-734X
Titre abrégé: Eur J Cardiothorac Surg
Pays: Germany
ID NLM: 8804069

Informations de publication

Date de publication:
03 04 2023
Historique:
received: 01 08 2022
revised: 13 12 2022
accepted: 21 12 2022
medline: 26 4 2023
pubmed: 23 12 2022
entrez: 22 12 2022
Statut: ppublish

Résumé

The purpose of this study was to evaluate the impact of a polyphenols-based treatment on the extrinsic mechanisms responsible for early bioprosthetic heart valve (BHV) degeneration. Structural degeneration can be driven by both extrinsic and intrinsic mechanisms. While intrinsic mechanisms have been associated with inherent biocompatibility characteristics of the BHV, the extrinsic ones have been reported to involve external causes, such as chemical, mechanical and hydrodynamic, responsible to facilitate graft damage. The chemical interaction and the stability degree between polyphenols and pericardial tissue were carefully evaluated. The detoxification of glutaraldehyde in commercial BHVs models and the protective effect from in vivo calcification were taken into relevant consideration. Finally, the hydrodynamic and biomechanical features of the polyphenols-treated pericardial tissue were deeply investigated by pulse duplicator and stress-strain analysis. The study demonstrated the durability of the polyphenols-based treatment on pericardial tissue and the stability of the bound polyphenols. The treatment improves glutaraldehyde stabilization's current degree, demonstrating a surprising in vivo anti-calcific effect. It is able to make the pericardial tissue more pliable while maintaining the correct hydrodynamic characteristics. The polyphenols treatment has proved to be a promising approach capable of acting simultaneously on several factors related to the premature degeneration of cardiac valve substitutes by extrinsic mechanisms.

Identifiants

pubmed: 36548449
pii: 6957091
doi: 10.1093/ejcts/ezac583
pii:
doi:

Substances chimiques

Glutaral T3C89M417N

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Biocompatibility Innovation

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Auteurs

Robert J Melder (RJ)

Mountain Hawk Consulting, Glen Allen, VA, USA.

Filippo Naso (F)

Biocompatibility Innovation Srl, Este, Italy.

Francesco Nicotra (F)

Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy.

Laura Russo (L)

Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy.
CÚRAM, SFI Research Centre for Medical Devices, National University of Ireland Galway, Galway, Ireland.

Ivan Vesely (I)

Class III Medical Device Consulting, Washington D.C. Metro Area, MD, USA.

Sugat R Tuladhar (SR)

Department of Cardiothoracic, Transplantation and Vascular Surgery, Lower Saxony Centre for Biomedical Engineering, Implant Research and Development, Hannover Medical School, Hannover, Germany.

Antonio M Calafiore (AM)

Department of Cardiovascular Sciences, Gemelli Molise, Campobasso, Italy.

Peter Zilla (P)

Christian Barnard Department of Cardiothoracic Surgery, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.

Alessandro Gandaglia (A)

Biocompatibility Innovation Srl, Este, Italy.

Sotiris Korossis (S)

Centre for Biological Engineering, Wolfson School of Mechanical, Electrical and Manufacturing Engineering, Loughborough University, Loughborough, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH